My Top COVID Stock for 2021

Zhiyuan Sun, The Motley Fool
·3 min read
My Top COVID Stock for 2021

If you invested $10,000 in shares of coronavirus vaccine manufacturer Moderna (NASDAQ: MRNA) last year, that principal would have grown to over $52,000 as of Jan. 15. After a decade of research and development and receiving over $3 billion in funding, Moderna has made a major scientific achievement by validating the use of messenger RNA (mRNA) technology in vaccines. Today, let's look at why Moderna is a top coronavirus stock for the new year.